TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility.
about
Parasitic Mistletoes of the Genera Scurrula and Viscum: From Bench to BedsideMLK3 Signaling in Cancer InvasionAnticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentStructural Basis for Treating Tumor Necrosis Factor (TNF )-associated Diseases with the Therapeutic Antibody InfliximabMechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapyEarly experience with novel immunomodulators for cancer treatmentNF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor.Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.The European approach to in-transit melanoma lesions.Recent advances in antimultiple myeloma drug development.Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant MelanomaActivated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.Interleukin-17 augments tumor necrosis factor α-mediated increase of hypoxia-inducible factor-1α and inhibits vasodilator-stimulated phosphoprotein expression to reduce the adhesion of breast cancer cells.Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survivalTNF-α -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.Probiotic modulation of dendritic cell function is influenced by ageing.Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility.TGF-β1, IL-6, and TNF-α in bronchoalveolar lavage fluid: useful markers for lung cancer?Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy.Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients.An evidence-based review of skin cancer rates on biologic therapies.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesMycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosisSensitive detection of pathway perturbations in cancersDR6 as a diagnostic and predictive biomarker in adult sarcoma.Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials.Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineNovel synthetic biscoumarins target tumor necrosis factor-α in hepatocellular carcinoma in vitro and in vivo.Do inflammatory bowel disease therapies cause cancer?Alternative sources of omega-3 fats: can we find a sustainable substitute for fish?Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin LymphomasNanoparticle preconditioning for enhanced thermal therapies in cancerCXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cellsNeutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells.Classification of current anticancer immunotherapiesExamination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Overexpression of nuclear apoptosis-inducing factor 1 altered the proteomic profile of human gastric cancer cell MKN45 and induced cell cycle arrest at G1/S phase.Reconfigurable microfluidics with integrated aptasensors for monitoring intercellular communication
P2860
Q26739988-2F104F57-79B0-480E-8F47-623CE1E463F3Q26746892-4ABA9A79-3B4C-433F-ABD9-013F1C29C014Q26749384-A36FFF44-BB5D-4DAD-9C3D-09CBFBEFBCBFQ27676857-03697AC1-F55B-41C8-A068-AE8498CFA520Q28083766-391C2CA2-A694-401F-8358-C50AEA75C7E6Q28241744-A6D55345-F6E0-46A9-94B5-73B623B3E1F5Q30832764-EAEF1CD8-456E-426A-997C-AB80C5EAC36FQ33325343-7DBF7470-8BA1-4141-9B93-3FD9333EBABDQ33327121-ABD0C87F-59F0-4471-AF9C-5D241CA43B2EQ33416297-97A18E69-CEAB-47BB-A265-8D1E7E6E2984Q33423772-2286F386-40B7-41FA-A56A-587B90BEFEC0Q33533655-44ACF7E8-7498-4BC8-BA9C-DFC0F8A90EEDQ33684844-2532FFB4-8F61-42AD-BFF8-76F65E36AF5DQ33728678-4AD7714D-DA37-44C3-A76B-1F2DB3446413Q33757402-022CB631-5DD5-4674-B47D-3314637684E6Q33782670-369A7EB8-290F-42A1-B044-28D6C2A62E81Q33799604-F65077AF-7D22-4091-8E98-B5D043261AB1Q33829542-B0D123C9-8CC1-47AE-B675-E0F251FEFD84Q33851625-A8F562C7-05DE-4F18-9AD4-AF140EA94D41Q34005611-4D5181E2-F995-4FC3-A3D9-A4F4E748342FQ34054797-D709770D-3627-4F19-9965-21FE01E3C394Q34107637-7E0AE176-6D3B-48B9-82EB-6AF55F4E2F47Q34139691-4BFCA614-8CC2-4086-8CED-1C17654944CCQ34241776-CDF668B8-B898-4958-A3A1-62BE7B1C511DQ34247915-619F87A2-95A7-4E88-B629-D3810746F2A5Q34261836-1ED9E140-20EA-4535-ADAC-07AD4970202DQ34340824-EE201E0A-BD31-47D7-A07E-5BAC3807B7A1Q34419681-B14DDFFC-471D-4203-9B95-FBD92806A8A4Q34509670-4B6B2978-49D4-4F77-88A1-3AF2C52C1093Q34613890-354966DC-38F3-4ACD-8441-AEF9CFE9BC16Q34650675-78F2D190-E96F-4E35-B4AC-1CCF67746BF4Q34670913-6B5D0DF3-165D-4D17-B19E-507C824C0BBCQ34987068-DC109C4A-1CF2-422C-AD7D-38BBFA90A006Q34990965-917942D0-4C2F-44CD-9D6D-16FDF5BC4EAAQ34997635-B9F191B1-421C-4AAF-81DA-4A97F93E6831Q35149564-460C90F6-97CB-48C2-9CB2-04583A5C34B9Q35149637-FD9C48B3-FDAB-4E99-BDF1-A0A95DB90ADFQ35167546-EF188DED-4EB2-4BF5-BAEF-DF97C4948EB2Q35187533-E614944F-460C-4A47-BB30-958881FFE3EFQ35285263-9378BB29-BC5B-47C7-BF38-EBFFC1F337D3
P2860
TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@ast
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@en
type
label
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@ast
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@en
prefLabel
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@ast
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@en
P2093
P1433
P1476
TNF-alpha in cancer treatment: ...... effects, and clinical utility.
@en
P2093
Alexander M M Eggermont
Remco van Horssen
Timo L M Ten Hagen
P304
P356
10.1634/THEONCOLOGIST.11-4-397
P577
2006-04-01T00:00:00Z